The Urokinase Receptor in Hematopoietic Stem Cells Mobilization

被引：3

作者：

Blasi, Francesco ^{[1
,2
]}

机构：

[1] Ist Sci San Raffaele, I-20132 Milan, Italy

[2] IFOM FIRC Inst Mol Oncol, I-20136 Milan, Italy

来源：

CURRENT PHARMACEUTICAL DESIGN | 2011年 / 17卷 / 19期

关键词：

Urokinase receptor; hematopoietic stem cells; mobilization; plasminogen activation; PLASMINOGEN-ACTIVATOR RECEPTOR; IN-VIVO; OBSTRUCTIVE NEPHROPATHY; HUMAN CARCINOMA; LINKER REGION; MIGRATION; UPAR; VITRONECTIN; COMPLEX; RECRUITMENT;

D O I：

10.2174/138161211796718206

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The receptor for urokinase plasminogen activator (uPAR) is required in hematopoietic stem/progenitor cells (HSC, HPC) mobilization in the mouse. Indeed, uPAR Ko mice are deficient both in retention and mobilization of HSC and HPC, because uPAR causes their retention in the BM through its interaction with the 4 1 integrin and at the same time its removal promotes their migration. Normally, the membrane signal is cleaved by plasmin which on one side releases the cells from their osteoblasts interaction and on the other produces a cleaved soluble uPAR product that stimulates mobilization. Available data suggest that a similar mechanism may take place in humans.

引用

页码：1911 / 1913

页数：3

共 50 条

[41] Low-density lipoprotein as a biomarker for the mobilization of hematopoietic stem cells in peripheral blood [J].

Ishihara, Tomoko ;

Mishima, Seiji ;

Kodama, Rumi ;

Yoshino, Isao ;

Adachi, Erika ;

Suyama, Tamiko ;

Shibata, Hiroshi ;

Taketani, Takeshi ;

Nagai, Atsushi .

TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (03) :539-541

[42] A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen [J].

Eastman, Boryana M. ;

Jo, Minji ;

Webb, Drue L. ;

Takimoto, Shinako ;

Gonias, Steven L. .

CELLULAR SIGNALLING, 2012, 24 (09) :1847-1855

[43] Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche [J].

Kruijf, Evert-Jan F. M. ;

Fibbe, Willem E. ;

van Pel, Melissa .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1466 (01) :24-38

[44] Stem cells and aging in the hematopoietic system [J].

Warren, Luigi A. ;

Rossi, Derrick J. .

MECHANISMS OF AGEING AND DEVELOPMENT, 2009, 130 (1-2) :46-53

[45] Aging of the hematopoietic stem cells niche [J].

Nakamura-Ishizu, Ayako ;

Suda, Toshio .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (04) :317-325

[46] Hematopoietic stem cells for cancer immunotherapy [J].

Gschweng, Eric ;

De Oliveira, Satiro ;

Kohn, Donald B. .

IMMUNOLOGICAL REVIEWS, 2014, 257 (01) :237-249

[47] Hematopoietic stem cells, infection, and the niche [J].

Prendergast, Aine M. ;

Essers, Marieke A. G. .

BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT, 2014, 1310 :51-57

[48] Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) [J].

Elhussieny, Ahmed ;

Nogami, Ken'ichiro ;

Sakai-Takemura, Fusako ;

Maruyama, Yusuke ;

Takemura, Natsumi ;

Soliman, Wael Talaat ;

Takeda, Shin'ichi ;

Miyagoe-Suzuki, Yuko .

STEM CELL RESEARCH & THERAPY, 2021, 12 (01)

[49] Hematopoietic stem cell mobilization: updated conceptual renditions [J].

Bonig, H. ;

Papayannopoulou, T. .

LEUKEMIA, 2013, 27 (01) :24-31

[50] Hematopoietic stem cell mobilization: updated conceptual renditions [J].

H Bonig ;

T Papayannopoulou .

Leukemia, 2013, 27 :24-31

← 1 2 3 4 5 →